These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 35426432)

  • 1. Evaluation of magnetic resonance imaging-based radiomics characteristics for differentiation of benign and malignant peripheral nerve sheath tumors in neurofibromatosis type 1.
    Ristow I; Madesta F; Well L; Shenas F; Wright F; Molwitz I; Farschtschi S; Bannas P; Adam G; Mautner VF; Werner R; Salamon J
    Neuro Oncol; 2022 Oct; 24(10):1790-1798. PubMed ID: 35426432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discrimination of benign, atypical, and malignant peripheral nerve sheath tumors in neurofibromatosis type 1 using diffusion-weighted MRI.
    Ristow I; Kaul MG; Stark M; Zapf A; Riedel C; Lenz A; Mautner VF; Farschtschi S; Apostolova I; Adam G; Bannas P; Salamon J; Well L
    Neurooncol Adv; 2024; 6(1):vdae021. PubMed ID: 38468867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant and Benign Peripheral Nerve Sheath Tumors in a Single Center: Value of Clinical and Ultrasound Features for the Diagnosis of Malignant Peripheral Nerve Sheath Tumor Compared With Magnetic Resonance Imaging.
    Jin Z; Wang C; Wang D; Li X; Guo W; Chen T
    J Ultrasound Med; 2024 Jan; 43(1):21-31. PubMed ID: 37772628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative Classification of Peripheral Nerve Sheath Tumors on MRI Using Radiomics.
    Jansma CYMN; Wan X; Acem I; Spaanderman DJ; Visser JJ; Hanff D; Taal W; Verhoef C; Klein S; Martin E; Starmans MPA
    Cancers (Basel); 2024 May; 16(11):. PubMed ID: 38893158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low mutation burden and frequent loss of CDKN2A/B and SMARCA2, but not PRC2, define premalignant neurofibromatosis type 1-associated atypical neurofibromas.
    Pemov A; Hansen NF; Sindiri S; Patidar R; Higham CS; Dombi E; Miettinen MM; Fetsch P; Brems H; Chandrasekharappa SC; Jones K; Zhu B; Wei JS; ; ; Mullikin JC; Wallace MR; Khan J; Legius E; Widemann BC; Stewart DR
    Neuro Oncol; 2019 Aug; 21(8):981-992. PubMed ID: 30722027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphology of the entering and exiting nerve as a differentiating feature of benign from malignant peripheral nerve sheath tumours of the brachial plexus.
    Pressney I; Khoo M; Khan R; Abernethy P; Hargunani R; Saifuddin A
    Skeletal Radiol; 2021 Aug; 50(8):1557-1565. PubMed ID: 33410965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of magnetic resonance imaging in the diagnostic evaluation of malignant peripheral nerve sheath tumors.
    Chhabra A; Soldatos T; Durand DJ; Carrino JA; McCarthy EF; Belzberg AJ
    Indian J Cancer; 2011; 48(3):328-34. PubMed ID: 21921333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging cellularity in benign and malignant peripheral nerve sheath tumors: Utility of the "target sign" by diffusion weighted imaging.
    Ahlawat S; Fayad LM
    Eur J Radiol; 2018 May; 102():195-201. PubMed ID: 29685535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of peripheral nerve sheath tumors in patients with neurofibromatosis type 1 using diffusion-weighted magnetic resonance imaging.
    Well L; Salamon J; Kaul MG; Farschtschi S; Herrmann J; Geier KI; Hagel C; Bockhorn M; Bannas P; Adam G; Mautner VF; Derlin T
    Neuro Oncol; 2019 Mar; 21(4):508-516. PubMed ID: 30496452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of plexiform and diffuse neurofibromas with malignant peripheral nerve sheath tumor in NF I patients: a whole-body MRI assessment.
    Attia S; Guirguis M; Le LQ; Chhabra A
    Skeletal Radiol; 2024 Apr; 53(4):769-777. PubMed ID: 37903998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Machine-Learning Approach to Differentiation of Benign and Malignant Peripheral Nerve Sheath Tumors: A Multicenter Study.
    Zhang M; Tong E; Hamrick F; Lee EH; Tam LT; Pendleton C; Smith BW; Hug NF; Biswal S; Seekins J; Mattonen SA; Napel S; Campen CJ; Spinner RJ; Yeom KW; Wilson TJ; Mahan MA
    Neurosurgery; 2021 Aug; 89(3):509-517. PubMed ID: 34131749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiological findings of malignant peripheral nerve sheath tumor: reports of six cases and review of literature.
    Yu YH; Wu JT; Ye J; Chen MX
    World J Surg Oncol; 2016 May; 14():142. PubMed ID: 27159980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Accuracy of PET/CT-Guided Percutaneous Biopsies for Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 Patients.
    Brahmi M; Thiesse P; Ranchere D; Mognetti T; Pinson S; Renard C; Decouvelaere AV; Blay JY; Combemale P
    PLoS One; 2015; 10(10):e0138386. PubMed ID: 26445379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The characteristics of 76 atypical neurofibromas as precursors to neurofibromatosis 1 associated malignant peripheral nerve sheath tumors.
    Higham CS; Dombi E; Rogiers A; Bhaumik S; Pans S; Connor SEJ; Miettinen M; Sciot R; Tirabosco R; Brems H; Baldwin A; Legius E; Widemann BC; Ferner RE
    Neuro Oncol; 2018 May; 20(6):818-825. PubMed ID: 29409029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Accuracy of MRI for the Detection of Malignant Peripheral Nerve Sheath Tumors: A Systematic Review and Meta-Analysis.
    Wilson MP; Katlariwala P; Low G; Murad MH; McInnes MDF; Jacques L; Jack AS
    AJR Am J Roentgenol; 2021 Jul; 217(1):31-39. PubMed ID: 33909462
    [No Abstract]   [Full Text] [Related]  

  • 16. Malignant Peripheral Nerve Sheath Tumor.
    James AW; Shurell E; Singh A; Dry SM; Eilber FC
    Surg Oncol Clin N Am; 2016 Oct; 25(4):789-802. PubMed ID: 27591499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study.
    Ferner RE; Golding JF; Smith M; Calonje E; Jan W; Sanjayanathan V; O'Doherty M
    Ann Oncol; 2008 Feb; 19(2):390-4. PubMed ID: 17932395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiomic biomarkers informative of cancerous transformation in neurofibromatosis-1 plexiform tumors.
    Uthoff J; De Stefano FA; Panzer K; Darbro BW; Sato TS; Khanna R; Quelle DE; Meyerholz DK; Weimer J; Sieren JC
    J Neuroradiol; 2019 May; 46(3):179-185. PubMed ID: 29958847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors.
    Watson KL; Al Sannaa GA; Kivlin CM; Ingram DR; Landers SM; Roland CL; Cormier JN; Hunt KK; Feig BW; Ashleigh Guadagnolo B; Bishop AJ; Wang WL; Slopis JM; McCutcheon IE; Lazar AJ; Torres KE
    J Neurosurg; 2017 Jan; 126(1):319-329. PubMed ID: 27035165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant peripheral nerve sheath tumor (MPNST) and MPNST-like entities are defined by a specific DNA methylation profile in pediatric and juvenile population.
    Patrizi S; Miele E; Falcone L; Vallese S; Rossi S; Barresi S; Giovannoni I; Pedace L; Nardini C; Masier I; Abballe L; Cacchione A; Russo I; Di Giannatale A; Di Ruscio V; Salgado CM; Mastronuzzi A; Ciolfi A; Tartaglia M; Milano GM; Locatelli F; Alaggio R
    Clin Epigenetics; 2024 Jan; 16(1):9. PubMed ID: 38178234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.